GlycoMimetics Insider Confidence Rewarded, Stock Hits US11m Market Cap

GLYC Stock  USD 0.35  0.04  12.90%   
About 58% of GlycoMimetics' investor base is looking to short. The analysis of the overall investor sentiment regarding GlycoMimetics suggests that many traders are alarmed. The current market sentiment, together with GlycoMimetics' historical and current headlines, can help investors time the market. In addition, many technical investors use GlycoMimetics stock news signals to limit their universe of possible portfolio assets.
  
Last week, GlycoMimetics, Inc. insiders, who had purchased shares in the previous 12 months were...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

GlycoMimetics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards GlycoMimetics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

GlycoMimetics Fundamental Analysis

We analyze GlycoMimetics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GlycoMimetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GlycoMimetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

GlycoMimetics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

GlycoMimetics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GlycoMimetics stock to make a market-neutral strategy. Peer analysis of GlycoMimetics could also be used in its relative valuation, which is a method of valuing GlycoMimetics by comparing valuation metrics with similar companies.

Peers

GlycoMimetics Related Equities

ANTXAN2 Therapeutics   21.90   
0%
100.0%
CUECue Biopharma   11.93   
0%
54.0%
FHTXFoghorn Therapeutics   2.57   
0%
11.0%
BCABBioatla   2.44   
0%
11.0%
TRVITrevi Therapeutics   2.13   
0%
9.0%
ASMBAssembly Biosciences   1.25   
0%
5.0%
ACHLAchilles Therapeutics   0.93   
0%
4.0%
SPROSpero Therapeutics   0.88   
0%
4.0%
IVAInventiva   1.12   
5.0%
0%
DYNDyne Therapeutics   1.67   
7.0%
0%
MLYSMineralys Therapeutics,   2.59   
11.0%
0%
TILInstil Bio   9.39   
42.0%
0%

Complementary Tools for GlycoMimetics Stock analysis

When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital